Skip to content

Opening book details…

About this Medicine article

Palumbo A, Bringhen S, Bruno B, et al. Melphalan 200 mg/m2 versus melphalan 100 mg/m2 in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study. Blood. 2010;115(10):1873–1879. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Publisher
American Society of Hematology (ISSN 0006-4971)
Published
2010
Language
EN
Field
Medicine (Health Sciences)